Monday, September 30, 2013 11:13:26 PM
Generex (GNBT) some years back kicked out the CEO Anna Gluskin and the Lawyer, Mark Flecher, was put in charge (a position he did not want). No communication with shareholders and they have yet to make any recent milestones (last 4 years), IMO.
AE37 has potential but IMO, not with this management team. Those that have stock for many years (myself included) are in a wait and see if anything can be done with AE37. They continue to issue warrants to survive.
There is great info on AE37 at DigitalTradz.com. Yahoo constantly bashes the members but it is expected from yahoo posters.
I'll leave it to others to comment on Oral-lyn (Ph3 back to Ph1), Oral Recosulin (Oraly-lyn India).
All my own opinion.
DH
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM